Par Drugs and Chemicals Limited — Board Meeting, 14-05-2026: Outcome of Board Meeting

Par Drugs & Chemicals Board approved audited FY26 results, posting an annual profit of ₹13.11 Cr on ₹103.66 Cr revenue. They also greenlit investments up to ₹90 Cr and are challenging ongoing SEBI action related to a past business transfer.